MaxLinear, Inc. (NYSE:MXL) VP Brendan Walsh sold 10,000 shares of the company’s stock in a transaction dated Thursday, September 2nd. The shares were sold at an average price of $53.50, for a total value of $535,000.00. Following the completion of the sale, the vice president now directly owns 146,932 shares of the company’s stock, valued at $7,860,862. The sale was disclosed in a filing with the SEC, which is available through this hyperlink.
Brendan Walsh also recently made the following trade(s):
Get MaxLinear alerts:
On Monday, August 30th, Brendan Walsh sold 10,000 shares of MaxLinear stock. The stock was sold at an average price of $52.55, for a total value of $525,500.00. On Friday, June 11th, Brendan Walsh sold 21,737 shares of MaxLinear stock. The stock was sold at an average price of $36.69, for a total transaction of $797,530.53.
NYSE MXL traded down $1.06 during trading hours on Tuesday, reaching $53.64. The company’s stock had a trading volume of 253,118 shares, compared to its average volume of 576,100. The firm has a fifty day simple moving average of $47.18 and a 200-day simple moving average of $40.50. The company has a debt-to-equity ratio of 0.79, a current ratio of 1.79 and a quick ratio of 1.32. MaxLinear, Inc. has a 52 week low of $20.91 and a 52 week high of $55.00. The stock has a market cap of $4.10 billion, a P/E ratio of -69.66, a P/E/G ratio of 1.57 and a beta of 1.96.
Hot Value Stocks To Invest In Right Now: Bristow Group, Inc.(VTOL)
Bristow Group Inc. provides aviation services to integrated, national, and independent offshore energy companies in the United States. It also offers commercial and public sector search and rescue services; and other ad hoc helicopter and fixed wing transportation services. As of March 31, 2021, the company had a fleet of 247 aircraft. It also has operations in Australia, Brazil, Canada, Chile, Colombia, Guyana, India, Mexico, Nigeria, Norway, Spain, Suriname, Trinidad, the United Kingdom. The company was founded 1948 and is headquartered in Houston, Texas.
Advisors’ Opinion:
- [By ]
Wheels Up Experience (NYSE:UP) and Bristow Group (NYSE:VTOL) are both small-cap aerospace companies, but which is the better investment? We will contrast the two companies based on the strength of their earnings, institutional ownership, profitability, analyst recommendations, risk, dividends and valuation.
Hot Value Stocks To Invest In Right Now: Sarepta Therapeutics, Inc.(SRPT)
We are a biopharmaceutical company focused on the discovery and development of unique RNA-targeted therapeutics for the treatment of rare, infectious and other diseases. Applying our proprietary, highly-differentiated and innovative platform technologies, we are able to target a broad range of diseases and disorders through distinct RNA-targeted mechanisms of action. We are primarily focused on rapidly advancing the development of our potentially disease-modifying DMD drug candidates, including our lead DMD product candidate, eteplirsen, designed to skip exon 51. On August 25, 2015, we announced the FDA filing of our NDA for eteplirsen for the treatment of DMD amenable to exon 51 skipping. The FDA postponed the Advisory Committee meeting for the review of the eteplirsen NDA previously scheduled for January 22, 2016 due to severe weather. Advisors’ Opinion:
- [By ]
Some of my readers may know Sarepta (Nasdaq: SRPT) well. This $9 billion gene-therapy company already has an FDA-approved product. Exondys 51, the first-ever FDA-approved treatment for a rare but deadly genetic disease called Duchenne muscular dystrophy (DMD), is already on the market. And just last month, the FDA granted priority review for SRPT’s second treatment for DMD, golodirsen, for DMD patients with a different genetic mutation.
- [By Dan Caplinger]
Wednesday was a bad day on Wall Street, as most major indexes finished lower. Small-cap stocks were hit harder than their large-cap counterparts, due in part to readings on the U.S. economy that signaled the possibility of a slowdown in the future. Moreover, downward pressure from some high-profile players weighed on overall market sentiment. NIO (NYSE:NIO), Brown-Forman (NYSE:BF-A) (NYSE:BF-B), and Sarepta Therapeutics (NASDAQ:SRPT) were among the worst performers. Here’s why they did so poorly.
Hot Value Stocks To Invest In Right Now: Daiichi Sankyo Company, Limited (DSKYF)
DAIICHI SANKYO COMPANY, LIMITED is a Japan-based holding company mainly engaged in the manufacture and sale of pharmaceuticals. The Company is involved in the research, development, manufacture and sale of pharmaceuticals, as well as the provision of intermediates and basic materials for pharmaceutical producing in Japan, the United States, Europe, China and Brazil markets. As of March 31, 2014, it had 100 subsidiaries and four associated companies. Advisors’ Opinion:
- [By ]
Daiichi Sankyo (OTCPK:DSKYF)
There are 4 members of the EGF receptor family, but in cancer research we tend to focus mainly on the first two: EGFR and HER2. But we are also gaining a better understanding of the third family member, HER3, which is an odd duck because of its willingness to form dimers not with itself, but with other members of the EGFR family. And it is highly active in PI3K/Akt signaling, as well. So it’s no surprise that companies are trying to exploit this receptor as a therapeutic target. DSKYF’s U3-1402 is an antibody-drug conjugate targeting HER3 and delivering a lethal payload to tumor cells. This phase 1/2 study focused on the use of this agent in metastatic breast cancer overexpressing HER3.
